Literature DB >> 7563341

Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes.

L Leibovitch1, R S Foster, K K Kopecky, J P Donohue.   

Abstract

PURPOSE: We evaluated the significance of retroperitoneal lymph nodes detected by computerized tomography (CT) of low stage nonseminomatous germ cell tumor patients.
MATERIALS AND METHODS: A blind retrospective review of 143 CTs of low stage nonseminomatous germ cell tumor revealed pathological stage A disease on 89 (62.2%) and pathological stage B disease on 54 (37.8%). A multivariate logistic regression model was used to evaluate the relationships between diameter of the retroperitoneal nodes detected in these CTs and pathological stage.
RESULTS: Based on this model, as the diameter of the nodes increased within a 0 to 25 mm. range, the likelihood of pathological stage B disease increased in a continuous fashion. Using a 3 mm. threshold to define nonmetastatic nodes the sensitivity and negative predictive value of CT based staging was 90%.
CONCLUSIONS: This measurement scheme improves the accuracy of staging compared to conventional methods.

Entities:  

Mesh:

Year:  1995        PMID: 7563341

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

Review 1.  Controversies in the management of early-stage germ cell tumors.

Authors:  Ann Tan; Timothy Gilligan
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

Review 2.  Controversies in the management of stage 1 non-seminomatous germ cell tumors.

Authors:  Sarah Coleman; Andrew Stephenson
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

Review 3.  Current management and management controversies in early- and intermediate-stage of nonseminoma germ cell tumors.

Authors:  Salim K Cheriyan; Marilin Nicholson; Ahmet M Aydin; Mounsif Azizi; Charles C Peyton; Wade J Sexton; Scott M Gilbert
Journal:  Transl Androl Urol       Date:  2020-01

4.  Volumetric assessment of lymph node metastases in patients with non-seminomatous germ cell tumours treated with chemotherapy.

Authors:  Carlos I Basilio-de-Leo; Christian I Villeda-Sandoval; Carolina Culebro-García; Francisco Rodríguez-Covarrubias; Ricardo A Castillejos-Molina
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

Review 5.  [Value of positron emission tomography in urological neoplasms: more form than substance?].

Authors:  J Müller; M Schrader; A J Schrader; M Höpfner; F Zengerling
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

6.  Performance characteristics of 18F-fluciclovine positron emission tomography/computed tomography prior to retroperitoneal lymph node dissection.

Authors:  Solomon L Woldu; Xiaosong Meng; Daniel Wong; Fady Baky; Vitaly Margulis; Yin Xi; Rathan M Subramaniam; Aditya Bagrodia
Journal:  Can Urol Assoc J       Date:  2022-03       Impact factor: 1.862

Review 7.  Management of patients with low-stage nonseminomatous germ cell testicular cancer.

Authors:  Andrew J Stephenson; Joel Sheinfeld
Journal:  Curr Treat Options Oncol       Date:  2005-09

8.  Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice.

Authors:  Axel Heidenreich; David Pfister
Journal:  Ther Adv Urol       Date:  2012-08

Review 9.  The management of low-stage non-seminomatous germ cell tumors.

Authors:  Louise Lim; Thomas Powles
Journal:  Oncol Rev       Date:  2012-10-08

Review 10.  Imaging 'the lost tribe': a review of adolescent cancer imaging. Part 1.

Authors:  P D Humphries; I Zerizer
Journal:  Cancer Imaging       Date:  2009-11-06       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.